Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote In favor of Your Favored Pizza Cover - 2Bad flu season getting worse; skyrocketing cases set state record
- 3Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah'
- 4A definitive Manual for Internet Mastering and Expertise Improvement
- 5Safeguarding Your Senior Protection Against Extortion and Tricks.
- The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- Scientists document a death from a meat allergy tied to certain ticks
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Teen drug use remains low, but survey finds small rise in heroin and cocaine use
- Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- The Extraordinary Excursion of Dental Embed Innovation
- Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
- Grasping the Qualifications Among Separation and Dissolution
- Step by step instructions to Advance the Eco-friendliness of Your Kona SUV
